Deal Making

Featured on Deal Making

J&J boosts autoimmune disease pipeline with $6.5bn Momenta buy
Deal-Making
J&J boosts autoimmune disease pipeline with $6.5bn Momenta buyJ&J boosts autoimmune disease pipeline with $6.5bn Momenta buy

Johnson & Johnson is acquiring Momenta in a $6.5 billion deal that brings a slate of experimental autoimmune disease therapies.

byFrank Vinluan
Aug 19, 2020
|
5 Min Read
Ligand strikes $516m deal to buy Pfenex for expression tech
Deal-Making
Ligand strikes $516m deal to buy Pfenex for expression techLigand strikes $516m deal to buy Pfenex for expression tech
byGareth Macdonald
Aug 17, 2020
2 Min Read
AbbVie ends vectorized antibody accord with Voyager
Deal-Making
AbbVie ends vectorized antibody accord with VoyagerAbbVie ends vectorized antibody accord with Voyager
byGareth Macdonald
Aug 7, 2020
2 Min Read
Base editing firm Beam licenses Oxford Biomedica’s vector tech
Deal-Making
Base editing firm Beam licenses Oxford Biomedica’s vector techBase editing firm Beam licenses Oxford Biomedica’s vector tech
byGareth Macdonald
Aug 4, 2020
2 Min Read
Thermo and Lyell team to boost T-cell fitness for CAR-T
Cell Culture Media
Thermo and Lyell team to boost T-cell fitness for CAR-TThermo and Lyell team to boost T-cell fitness for CAR-T
byGareth Macdonald
Aug 3, 2020
2 Min Read
MolMed latest add-on for expansion hungry AGC Biologics
Analytical
MolMed latest add-on for expansion hungry AGC BiologicsMolMed latest add-on for expansion hungry AGC Biologics
byDan Stanton
Aug 3, 2020
2 Min Read

More from Deal Making

Forge Bio’s combo model for gene therapies attracts $40m in funding
Deal-Making
Forge Bio’s combo model for gene therapies attracts $40m in funding
Forge Bio’s combo model for gene therapies attracts $40m in funding
Jul 23, 2020
|
5 Min Read
byFrank Vinluan
GSK gains 10% stake in mRNA vaccine developer Curevac in manufacturing deal
Deal-Making
GSK gains 10% stake in mRNA vaccine developer Curevac in manufacturing deal
GSK gains 10% stake in mRNA vaccine developer Curevac in manufacturing deal
Jul 21, 2020
|
2 Min Read
byGareth Macdonald
Catalent expands contract with Humanigen for COVID-19 MAb
Deal-Making
Catalent expands contract with Humanigen for COVID-19 MAb
Catalent expands contract with Humanigen for COVID-19 MAb
Jul 17, 2020
|
3 Min Read
byDan Stanton
Amgen invests further $421m in China's Beigene
Global Markets
Amgen invests further $421m in China's Beigene
Amgen invests further $421m in China's Beigene
Jul 15, 2020
|
2 Min Read
bySarah de Crescenzo
Samsung Biologics eyes fourth plant as capacity fills
Deal-Making
Samsung Biologics eyes fourth plant as capacity fills
Samsung Biologics eyes fourth plant as capacity fills
Jul 13, 2020
|
2 Min Read
byDan Stanton
Novavax says COVID $1.6bn funding helps secure US-based supply chain
Global Markets
Novavax says COVID $1.6bn funding helps secure US-based supply chain
Novavax says COVID $1.6bn funding helps secure US-based supply chain
Jul 8, 2020
|
3 Min Read
byDan Stanton
Rentschler and Vetter team to take on rising drug cost and complexity
Deal-Making
Rentschler and Vetter team to take on rising drug cost and complexity
Rentschler and Vetter team to take on rising drug cost and complexity
Jul 8, 2020
|
2 Min Read
byGareth Macdonald
Instant caRNA? Tesla touts RNA bioreactor it is developing with Curevac
Therapeutic Class
Instant caRNA? Tesla touts RNA bioreactor it is developing with Curevac
Instant caRNA? Tesla touts RNA bioreactor it is developing with Curevac
Jul 6, 2020
|
2 Min Read
byGareth Macdonald
CSL Behring strengthens gene therapy ambition in $450m deal
Deal-Making
CSL Behring strengthens gene therapy ambition in $450m deal
CSL Behring strengthens gene therapy ambition in $450m deal
Jun 27, 2020
|
2 Min Read
byDan Stanton
Sanofi pays Translate $425m to expand mRNA partnership
Deal-Making
Sanofi pays Translate $425m to expand mRNA partnership
Sanofi pays Translate $425m to expand mRNA partnership
Jun 24, 2020
|
2 Min Read
byDan Stanton
Nex-T up: Bristol-Myers using machine learning to optimize future CAR-T
Therapeutic Class
Nex-T up: Bristol-Myers using machine learning to optimize future CAR-T
Nex-T up: Bristol-Myers using machine learning to optimize future CAR-T
Jun 23, 2020
|
2 Min Read
byDan Stanton
Emergent to add gene therapy capacity through $75m plant expansion
Facilities & Capacity
Emergent to add gene therapy capacity through $75m plant expansion
Emergent to add gene therapy capacity through $75m plant expansion
Jun 22, 2020
|
3 Min Read
byGareth Macdonald
Inhouse and out: AstraZeneca secures COVID-19 vaccine capacity
Facilities & Capacity
Inhouse and out: AstraZeneca secures COVID-19 vaccine capacity
Inhouse and out: AstraZeneca secures COVID-19 vaccine capacity
Jun 17, 2020
|
3 Min Read
byDan Stanton
Is Catalent set to make another major acquisition?
Deal-Making
Is Catalent set to make another major acquisition?
Is Catalent set to make another major acquisition?
Jun 11, 2020
|
3 Min Read
byDan Stanton
COVID-19 round-up: Vaccine capacity M&A, deals and task orders
Deal-Making
COVID-19 round-up: Vaccine capacity M&A, deals and task orders
COVID-19 round-up: Vaccine capacity M&A, deals and task orders
Jun 4, 2020
|
3 Min Read
byDan Stanton
Thermo Fisher adding 12,000L to bio-capacity with Swiss plant from CSL
Deal-Making
Thermo Fisher adding 12,000L to bio-capacity with Swiss plant from CSL
Thermo Fisher adding 12,000L to bio-capacity with Swiss plant from CSL
Jun 2, 2020
|
3 Min Read
byDan Stanton
Oxford Biomedica to make AstraZeneca’s coronavirus vaccine for trials
Deal-Making
Oxford Biomedica to make AstraZeneca’s coronavirus vaccine for trials
Oxford Biomedica to make AstraZeneca’s coronavirus vaccine for trials
May 29, 2020
|
3 Min Read
byGareth Macdonald
AveXis redeploying CDMO gene therapy capacity to support COVID-19 project
Facilities & Capacity
AveXis redeploying CDMO gene therapy capacity to support COVID-19 project
AveXis redeploying CDMO gene therapy capacity to support COVID-19 project
May 28, 2020
|
3 Min Read
byDan Stanton
Merck exercises option to use Vaxxas vaccine delivery patch
Deal-Making
Merck exercises option to use Vaxxas vaccine delivery patch
Merck exercises option to use Vaxxas vaccine delivery patch
May 28, 2020
|
2 Min Read
byGareth Macdonald
Viral vector vaccines and a nucleotide: Merck enters the COVID game
Bioprocess Insider
Viral vector vaccines and a nucleotide: Merck enters the COVID game
Viral vector vaccines and a nucleotide: Merck enters the COVID game
May 27, 2020
|
3 Min Read
byBPI Staff
Cytiva to help Takara gear up for COVID-19 vaccine production
Upstream & Downstream Processing
Cytiva to help Takara gear up for COVID-19 vaccine production
Cytiva to help Takara gear up for COVID-19 vaccine production
May 22, 2020
|
2 Min Read
byGareth Macdonald
Aragen and Avid team to offer combined development and manufacturing services
Deal-Making
Aragen and Avid team to offer combined development and manufacturing services
Aragen and Avid team to offer combined development and manufacturing services
May 12, 2020
|
2 Min Read
byDan Stanton
Emergent buoyed by COVID-19 related CDMO business in Q1
Deal-Making
Emergent buoyed by COVID-19 related CDMO business in Q1
Emergent buoyed by COVID-19 related CDMO business in Q1
May 12, 2020
|
2 Min Read
byGareth Macdonald
AstraZeneca teams with Oxford University, enters COVID-19 vaccine race
Deal-Making
AstraZeneca teams with Oxford University, enters COVID-19 vaccine race
AstraZeneca teams with Oxford University, enters COVID-19 vaccine race
Apr 30, 2020
|
1 Min Read
byDan Stanton
Catalent to provide large-scale fill/finish for J&J coronavirus vaccine project
Facilities & Capacity
Catalent to provide large-scale fill/finish for J&J coronavirus vaccine project
Catalent to provide large-scale fill/finish for J&J coronavirus vaccine project
Apr 30, 2020
|
2 Min Read
byDan Stanton
Pierre Fabre offloading MAb plant as it moves away from contract manufacturing
Facilities & Capacity
Pierre Fabre offloading MAb plant as it moves away from contract manufacturing
Pierre Fabre offloading MAb plant as it moves away from contract manufacturing
Apr 30, 2020
|
1 Min Read
byDan Stanton
Fujifilm licenses AAV vector tech to speed gene therapy production
Upstream & Downstream Processing
Fujifilm licenses AAV vector tech to speed gene therapy production
Fujifilm licenses AAV vector tech to speed gene therapy production
Apr 28, 2020
|
2 Min Read
byBPI Staff
Evotec extends Takeda pact to gene therapy
Therapeutic Class
Evotec extends Takeda pact to gene therapy
Evotec extends Takeda pact to gene therapy
Apr 16, 2020
|
3 Min Read
bySten Stovall
Sanofi and GSK will use Flublok and AS03 tech to make coronavirus vaccine
Deal-Making
Sanofi and GSK will use Flublok and AS03 tech to make coronavirus vaccine
Sanofi and GSK will use Flublok and AS03 tech to make coronavirus vaccine
Apr 16, 2020
|
3 Min Read
byGareth Macdonald
Orgenesis signs muscle-derived stem cell pact with Revatis
Deal-Making
Orgenesis signs muscle-derived stem cell pact with Revatis
Orgenesis signs muscle-derived stem cell pact with Revatis
Apr 13, 2020
|
2 Min Read
byGareth Macdonald

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Ask the Expert webcasts
ATE Webcasts
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Ask the Expert webcasts
ATE Webcasts
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Repligen white paper
Sponsored Content
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System

Oct 25, 2024

Solventum white paper
Sponsored Content
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process

Oct 25, 2024

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024